CCA
GOSS icon

Catalyst Capital Advisors’s Gossamer Bio GOSS Stock Holding History

Catalyst Capital Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-350
Closed -$8K – 443
2019
Q1 		$8K Buy
+350
New +$7.3K ﹤0.01% 314

Other funds holding GOSS

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Catalyst Capital Advisors's GOSS Position: Q2 2019 in Review

Catalyst Capital Advisors sold out of Gossamer Bio (GOSS) in Q2 2019, closing a stake of 350 shares — an estimated $8K sold.

Catalyst Capital Advisors first reported a position in GOSS in Q1 2019 and held it in 1 quarter. The position peaked at $8K in Q1 2019. 74 funds tracked by Wall St. Rank hold GOSS as of Q2 2019.

  • Catalyst Capital Advisors reported no remaining Gossamer Bio position as of Q2 2019 after selling out during the quarter.
  • Catalyst Capital Advisors sold 350 Gossamer Bio shares in Q2 2019, an estimated $8K.
  • Catalyst Capital Advisors first reported a position in Gossamer Bio in Q1 2019 and held it in 1 quarter.
  • Catalyst Capital Advisors's Gossamer Bio position peaked at $8K in Q1 2019.
  • 74 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2019.

Based on Catalyst Capital Advisors's 13F filing for Q2 2019, filed 8 Aug 2019.